Can a video chat program boost HIV prevention in rural drug users?

NCT ID NCT06799702

Not yet recruiting Knowledge-focused Sponsor: University of Georgia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test whether an 8-session telehealth program can help people who inject drugs in the rural South build coping skills and resilience. The goal is to improve access to HIV prevention (PrEP), hepatitis C treatment, and medication for opioid use disorder. The study will enroll 40 participants and focus on whether the program is feasible, acceptable, and easy to use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Telehealth behavioral intervention
What this could lead to: If successful, this could point toward a scalable way to improve HIV prevention and hepatitis C care for people who inject drugs in underserved rural areas.
What could go wrong: This is a very small pilot study (40 participants) focused on feasibility, not on proving health outcomes. The intervention may not be effective or acceptable in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C (HCV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence hepatitis C virus infection prevention target HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATITIS C (HCV) HIV PRE-EXPOSURE PROPHYLAXIS OPIOID-USE DISORDER

Contacts and locations

Locations

MedLink Georgia

Colbert, Georgia, 30628, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.